Perspective Therapeutics Reports Q2 2026 Financial Results

What Happened

• On August 10, 2026, Perspective Therapeutics, Inc. (NASDAQ: CATX) issued a press release announcing its financial results for the quarter ended June 30, 2026 and provided recent business highlights. The press release is furnished as Exhibit 99.1 to the Form 8‑K.
• Also on August 10, 2026, the company posted an updated corporate presentation to its website (www.perspectivetherapeutics.com); the presentation is filed as Exhibit 99.2 to the Form 8‑K. The report was signed by Joel Sendek, Chief Financial Officer.

Key Details

• Filing date: August 10, 2026; reporting period: quarter ended June 30, 2026.
• Exhibit 99.1 = press release with quarterly results and business highlights; Exhibit 99.2 = updated corporate presentation.
• Interactive XBRL cover page (Exhibit 104) was included with the filing.
• Report signed by Joel Sendek, CFO, on behalf of the company.

Why It Matters

• The 8‑K makes the company’s Q2 2026 quarterly results and updated investor materials publicly available—important sources for assessing recent revenue, expenses, cash position, and business milestones.
• Investors should review the attached press release (Exhibit 99.1) and the updated presentation (Exhibit 99.2) for the specific financial figures and operational updates that could affect the company’s outlook and valuation.